NAV
1 known investors
NAV Vaccine develops preventive and therapeutic drugs using immune system technology. The company focuses on cancer treatments, immunotherapy combination therapies, viral prevention vaccines, and tissue regeneration therapeutics.
Investors · 1
Frequently asked questions
- What does NAV do?
- NAV Vaccine develops preventive and therapeutic drugs using immune system technology. The company focuses on cancer treatments, immunotherapy combination therapies, viral prevention vaccines, and tissue regeneration therapeutics.
- Who are NAV's investors?
- NAV's investors include IMM Investment Japan.